Re:The FDA's notes from its visit to Theranos' labs don't lo...
by JoeAltmaier on Wednesday October 28, 2015 @10:05AM
(#10464491)
Seem overvalued. But valuations are on future value. So if they could get their test through the mill, what would they be worth? Multiply by your estimate of their chances. Probably << $9B
Theranos uses non-venous blood for their proprietary tests (currently only 1 test) and rest 99.9% (figuratively speaking) tests uses venous blood in traditional diagnostic equipment.
Back to the same question - If almost all of their tests are done using traditional equipments, then why $9B valuation?